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Alcohol and Cardiovascular Health
The Razor-Sharp Double-Edged Sword
James H. O’Keefe, MD, FACC,* Kevin A. Bybee, MD,* Carl J. Lavie, MD, FACC†
Kansas City, Missouri; and New Orleans, Louisiana
An extensive body of data shows concordant J-shaped associations between alcohol intake and a variety of ad-
verse health outcomes, including coronary heart disease, diabetes, hypertension, congestive heart failure,
stroke, dementia, Raynaud’s phenomenon, and all-cause mortality. Light to moderate alcohol consumption (up
to 1 drink daily for women and 1 or 2 drinks daily for men) is associated with cardioprotective benefits, whereas
increasingly excessive consumption results in proportional worsening of outcomes. Alcohol consumption confers
cardiovascular protection predominately through improvements in insulin sensitivity and high-density lipoprotein
cholesterol. The ethanol itself, rather than specific components of various alcoholic beverages, appears to be the
major factor in conferring health benefits. Low-dose daily alcohol is associated with better health than less fre-
quent consumption. Binge drinking, even among otherwise light drinkers, increases cardiovascular events and
mortality. Alcohol should not be universally prescribed for health enhancement to nondrinking individuals owing
to the lack of randomized outcome data and the potential for problem drinking. (J Am Coll Cardiol 2007;50:
1009–14) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.04.089d
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dIt has long been recognized that the problems with alcohol relate
not to the use of a bad thing, but to the abuse of a good thing.
Abraham Lincoln (1)
lcohol (ethanol) consumption is analogous to the prover-
ial double-edged sword, and perhaps no other factor in
ardiovascular (CV) health is capable of cutting so deeply in
ither direction depending on how it is used. Accumulating
cientific evidence indicates that light to moderate drinking
one on a daily basis may significantly reduce the risks of
oronary heart disease (CHD) and all-cause mortality. In
ontrast, excessive alcohol intake and binge drinking are
oxic to both the heart and overall health and are the third
eading cause of premature death among Americans.
The purpose of the present review is to: 1) outline the
pecific benefits and risks of alcohol, and the threshold of
ntake at which drinking becomes a health danger rather
han an advantage; 2) detail the mechanisms whereby
lcohol confers cardioprotection; and 3) discuss the ideal
uantities, drinking patterns, and beverages, and which
ndividuals are most likely to benefit.
lcohol and Health: The J-Shaped Curve
he health effects of ethanol are dependent on the amount
f alcohol consumed and the pattern of drinking. Most
tudies report J-shaped curves, whereby light to moderate
rom the *Mid America Heart Institute, University of Missouri, Kansas City,
issouri; and the †Ochsner Medical Center, New Orleans, Louisiana.a
Manuscript received February 14, 2007; revised manuscript received April 19,
007, accepted April 30, 2007.rinkers have less risk than abstainers, and heavy drinkers
re at the highest risk. A recent meta-analysis of over 1
illion individuals showed that consumption of 1 drink
aily by women and 1 or 2 drinks daily by men was
ssociated with a reduction in total mortality of 18% (2). On
he other hand, intakes of 2 drinks daily in women and 3
rinks daily in men were associated with increased mortality
n a dose-dependent fashion (Fig. 1).
The possible CV benefits appear to be the most impor-
ant health effects of light to moderate drinking, with most
tudies showing CHD risk reductions of approximately 30%
o 35% (3,4). In the INTER-HEART study (5), involving
7,000 patients from 52 countries, regular alcohol con-
umption was associated with a reduced incidence of myo-
ardial infarction (MI) in both genders, and in all adult age
roups. Light to moderate drinking is associated with
mproved CV health in higher-risk individuals, such as
hose with known CHD and/or diabetes, but it also may
educe CV risk even in lower-risk individuals. A subgroup
tudy taken from the total cohort of 51,000 men in the
ealth Professionals Follow-Up Study focused on the
ffects of alcohol in the 8,867 men (mean age 57 years) who
ollowed all 4 of the major healthy lifestyle behaviors
abstention from smoking, maintaining a body mass index
25 kg/m2, exercising at least 30 min daily, and eating a
ealthy diet). That study found that even in men who were
lready following a very healthy lifestyle, the consumption
f 1 or 2 drinks per day was associated with a 40% to 50%
ecreased risk of MI (Fig. 2) (6). Patients with hypertension
lso appear to benefit from moderate alcohol consumption.
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study of 11,711 hypertensive
men, 1 drink per day reduced the
risk of acute MI by approxi-
mately 30% (7). In contrast, al-
cohol increases blood pressure in a
dose-dependent fashion at intakes
above 2 drinks daily, and exces-
sive ethanol intake is one of the
most common reversible causes
f hypertension (8). Acute ethanol exposure causes a nega-
ive inotropic effect on the myocardium, and heavy alcohol
se has been associated with both declining ejection fraction
nd progressive left ventricular hypertrophy (9,10). Yet,
ight to moderate drinking has been associated with a
ubstantially reduced risk of congestive heart failure, espe-
ially for those with CHD (11). Light to moderate alcohol
ntake is also associated with lower risks of both ischemic
troke (Fig. 3) (12,13) and dementia (14). Consistent
-shaped curves demonstrate increased risks for stroke,
specially hemorrhagic stroke, (15) and dementia at heavier
evels of alcohol consumption (12–15).
Studies indicate that alcohol, when used in moderation,
as an antiatherosclerotic effect. Investigators have reported
hat moderate alcohol use is associated with a decreased
therosclerotic burden as assessed by coronary angiography
16), computerized tomography-detected coronary calcium
Fig. 4) (17), and carotid ultrasound (18). Moderate alcohol
ntake has also been associated with a decreased incidence of
eripheral arterial disease (10). Recent Data from the Fra-
ingham study indicate that a J-shaped relationship even
xists between alcohol intake and Raynaud’s phenomenon,
hereby light to moderate drinkers have a lower incidence of
aynaud’s compared with abstainers or heavier drinkers (19).
Figure 1 Alcohol and All-Cause Mortality
The relationship of daily alcohol consumption to the relative risk of all-cause
mortality in men and women. Reproduced with permission from DiCastelnuovo
et al. (2).
Abbreviations
and Acronyms
CHD  coronary heart
disease
CV  cardiovascular
HDL  high-density
lipoprotein
MI  myocardial infarctionow Alcohol Confers Cardioprotection
xisting data suggest that light to moderate alcohol con-
umption confers CV protection predominantly through
nhancement of insulin sensitivity, and elevation of high-
ensity lipoprotein (HDL) cholesterol; however, improve-
ents in inflammation and abdominal obesity may also be
laying lesser roles in the apparent alcohol-related cardio-
rotection (20). Because these parameters are interrelated
ia complex metabolic pathways, the exact contribution of
ach is difficult to tease out statistically (4,21). Alcohol
ntake increases HDL levels in a dose-dependent fashion.
Figure 2 Alcohol Intake and Risk of MI
in Men Following a Healthy Lifestyle
Moderate alcohol intake (1 to 2 drinks per day) reduced the rate of myocardial
infarction (MI) in this group of 8,867 middle-aged males already following
healthy lifestyle recommendations (6).
Figure 3 Alcohol and Stroke Risk
Relationship between daily alcohol and ischemic stroke. This was fully adjusted
for the usual stroke factors. OR  odds ratio. Reproduced with permission
from Sacco et al. (12).
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September 11, 2007:1009–14 Alcohol and Cardiovascular Healthor example, HDL will rise about 5% with 1 drink per day
nd 10% with 2 to 3 drinks per day (4,22–24). The
ose-dependent effect of alcohol on HDL contrasts with the
-shaped relationship between alcohol and adverse health
utcomes. A recent cross-sectional study of 3,700 Russian
ndividuals between the ages of 18 and 75 years reported
hat 75% of male and 47% of female Russians chronically
onsume excessive amounts of alcohol (25). Consequently,
dults in Russia have significantly higher mean levels of
DL cholesterol compared with other countries (26).
espite higher HDL levels, Russia has higher age-adjusted
ates of CV disease and all-cause mortality than Western
urope or the U.S. (25,26).
The 2007 American Diabetic Association guidelines
tate, “In individuals with diabetes, light to moderate
lcohol intake (1 or 2 drinks per day; 15 to 30 g alcohol) is
ssociated with a decreased risk of CV disease, which does
ot appear to be due to an increase in HDL cholesterol”
27). Consuming a moderate amount of alcohol, like exer-
ising aerobically, will increase insulin sensitivity and glu-
ose metabolism for the ensuing 12 to 24 h (22,28).
andomized placebo-controlled trials in nondiabetic indi-
iduals showed that 2 drinks per day will significantly lower
asting insulin and postprandial insulin levels and increase
nsulin sensitivity (23,24). Ethanol, when consumed by
iabetic patients in small to moderate quantities with or
mmediately before the evening meal, has been shown to
ubstantially reduce the glucose excursion following the
eal (Fig. 5) (22,28). The biologic mechanism whereby
lcohol improves insulin sensitivity appears to involve sup-
ression of fatty acid release from adipose tissue (29). This
eduction in fatty acids decreases substrate competition in
he Krebs cycle of skeletal muscles, thereby facilitating
lucose metabolism (29).
One or 2 drinks per day lowers triglycerides modestly (7%
Figure 4 Alcohol and Coronary Calcium
The likelihood of having extensive coronary calcification on computerized
tomography scanning was reduced in those who consumed 1 to 2 drinks
daily. Data from Vliegenthart et al. (17).
 substantially reduced postprandial g
wito 10%), but alcohol consumption above 2 drinks per dayncreases triglycerides in a dose-dependent fashion (23,24).
ndividuals who consume light to moderate amounts of
lcohol on a daily basis have less abdominal obesity than do
ondrinkers, but those who consume more than 2 drinks per
ay have increased abdominal obesity that rises in propor-
ion to the amount of alcohol consumed (29,30). Intra-
bdominal fat is strongly linked with low HDL levels,
nsulin resistance, and inflammation, suggesting that alco-
ol’s health effects may in part be mediated by its influence
n abdominal obesity (29).
The anti-inflammatory effects of light to moderate alco-
ol intake were documented by reductions in C-reactive
rotein in a small randomized controlled trial and a large
bservational study (31,32), and in tumor necrosis factor
lpha, interleukin-6, and fibrinogen in other studies (Fig. 6)
10,33).
Consumption of wine, more so than beer or spirits, has
een independently associated with improvements in heart
ate variability, a marker of autonomic balance (34). This
ugmentation of the vagal tone could be a factor in
mproving CHD prognosis (35).
avorable Effects
n Diabetes and Metabolic Syndrome
lcohol, with its favorable effects on HDL, insulin action,
nd inflammation, may be particularly beneficial for indi-
iduals with abnormal glucose metabolism and/or insulin
esistance. Recent studies indicate that diabetes, prediabe-
es, or the metabolic syndrome is present in approximately 1
f every 3 American adults (36) and 2 of 3 patients who
resent with symptomatic CHD (37). Light to moderate
lcohol intake is associated with reductions in both the
revalence and incidence of diabetes. A large meta-analysis
f 370,000 individuals followed for 12 years showed a 30%
Figure 5 Wine With Meal Reduced Postprandial Glucose
In this group of type 2 diabetic patients, wine with the meal (solid circles),
for the subsequent 6 h        compared
h subjects who drank a wine placebo (open circles). Reproduced with per-
mission from Greenfield et al. (22).
reduction in new diabetes in people who consumed 1 to 2
drinks per day (Fig. 7) (38).
Moderate alcohol consumption is also associated with
lower rates of the metabolic syndrome. In a recent study of
1,966 men followed for 13 years, alcohol intake of approx-
imately 1 drink daily was associated with a 40% decreased
risk of having the metabolic syndrome (39). That same
study demonstrated a 39% risk-adjusted decrease in risk of
CHD events that was more apparent in those with the
metabolic syndrome than in those without it. Moderate
alcohol intake is associated with similar reductions in
relative risk of CHD in diabetic and nondiabetic cohorts;
although superior reductions in absolute risk of CHD are
seen in diabetic patients owing to their higher overall event
rates (40).
Drinking Patterns, Beverage Choices
The ethanol itself, rather than a specific component of wine,
beer, or spirits, appears to be the major factor in conferring
the health benefits (4,21), and most studies show equal
protection from all types of alcohol. Red wine, however, has
been shown to have higher levels of bioflavonoids (with
antioxidant, antiplatelet, and antiendothelin-1 effects) com-
pared with white wine and other forms of alcohol (41).
Nevertheless, the developing consensus suggests that the
specific alcoholic beverage is less important than the quan-
tity and pattern of the alcohol intake (42).
Studies of both men and women have shown that daily
alcohol intake provides superior health benefits compared
with less frequent consumption (4,21,43– 45). In one
large study, a 37% decrease in CHD risk was present for
those who drank 5 to 7 days per week compared with
those who drank less than once per week (4). This may be
due to the fact that the alcohol-induced favorable
changes in insulin sensitivity, HDL cholesterol, and
inflammation are transient, reverting back to baseline
within 24 h (43). Some studies show that alcohol is most
cardioprotective when consumed before or during a meal
(44); the improvements in postprandial glucose metabo-
lism noted with light to moderate drinking lend biologic
plausibility to this finding (22).
Although Mark Twain once quipped, “Everything in
moderation, including moderation,” studies indicate that
even occasional immoderate drinking presents a health risk.
Binge drinking increases risk of MI, all-cause mortality, and
other adverse outcomes even among otherwise light drinkers
(4,44–46). In the MONICA (Monitoring of Trends and
Determinants in Cardiovascular Disease) project, men who
consumed 5 drinks per drinking day had a 2-fold in-
creased risk for acute MI and all-cause mortality compared
with those who did not drink at all (47). In that same study,
men who consumed 1 or 2 drinks daily had a 50% reduction
in risk of acute MI compared with abstainers.
Cardioprotective alcohol intake is generally defined as 1
or 2 drinks per day for men and 1 drink per day for women
(2,4,27). A drink is considered to be 12 oz beer, 5 oz wine,
1.5 oz 80-proof spirits, or 1 oz 100-proof spirits, all of
which contain approximately 13 g to 15 g ethanol.
Summary and Recommendations
The cumulative scientific evidence demonstrates concordant
J-shaped associations between alcohol intake and a variety
of adverse health outcomes. These data suggest that alcohol
consumption, like exercise, is most cardioprotective when
done daily and in moderation (29). It is tempting, based on
the current wealth of evidence, to recommend small daily
doses of alcohol (e.g., 1 drink per day) to nondrinkers with
or at high risk for CV disease. Guidelines for sensible
drinking developed in the United Kingdom state, “Middle-
aged or elderly men and postmenopausal women who drink
infrequently or not at all may wish to consider the possibility
that light drinking may benefit their health” (42). We
occasionally make this recommendation to patients well
Figure 6 Alcohol and CRP Levels
Alcohol was associated with a reduction in C-reactive protein (CRP), particularly
at 5 to 7 drinks per week. Reproduced with permission from Albert et al. (31).
Figure 7 Alcohol and Risk of Diabetes
Alcohol intake and incidence of new
type 2 diabetes. Data from Koppes et al. (38).
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September 11, 2007:1009–14 Alcohol and Cardiovascular Healthnown to us who have no personal or family history of
ubstance abuse, have no history of depression or bipolar
isorder, and are nonsmokers. However, light to moderate
rinking cannot be universally recommended to the general
ublic or even patients with CV disease.
Despite convincing observational data and randomized
rials using surrogate end points suggesting that hormone
eplacement therapy in women and antioxidant vitamins
mproved cardiovascular outcomes, subsequent large ran-
omized outcomes trials showed the opposite (48). Ran-
omized trials of alcohol for improving clinical outcomes
ave not been done, and residual unmeasured confounding
actors could be playing a role in the benefits associated with
ight to moderate drinking in observational studies (49–51).
Sobering statistics warn that moderate daily drinking is a
lippery slope that many individuals cannot safely navigate.
eavy drinking is the source of much individual and societal
uffering and morbidity; and some studies suggest that
lcohol abuse and binge drinking have been on the rise over
he past 15 years (52). Alcohol abuse, the third largest
reventable cause of death, is responsible for killing more
han 100,000 Americans annually (52). Excessive alcohol
ntake increases the risks of motor vehicle accidents, stroke,
ardiomyopathy, cardiac dysrhythmia, sudden cardiac arrest,
uicide, cancer (most notably of the breast and gastrointes-
inal tract), cirrhosis, fetal alcohol syndrome, sleep apnea,
nd all-cause mortality (44–46,52). The latest American
eart Association guidelines caution people not to start
rinking if they do not already drink alcohol, because it is
ot possible to predict in which people alcohol abuse will
ecome a problem (10). Until we have more randomized
utcome data, and tools for predicting susceptibility to
roblem drinking, it would seem prudent to encourage
hysicians and patients to focus on more innocuous inter-
entions to prevent CHD.
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